Platforms cancer data

© everythingspossible/fotolia.com

 

MITO: Models in Translational Oncology

{captionTextPlaceholder} © MITO

A new database of preclinical models - Participate and benefit from sharing information and resources, support the 3R principle.

To faithfully recapitulate extremely heterogeneous cancer diseases, researchers use preclinical models ranging from tumor cells in culture over in vivo equivalents to various model organisms. MiTO aims to facilitate the exchange of standardized model data and biological resources to avoid double developments. Utilization of MiTO is an active contribution to the 3R principle (replace, refine, reduce animals in research) and represents a relevant animal welfare action.
More about MITO

Contact

Dr. Karin Müller-Decker

Deutsches Krebsforschungszentrum

Im Neuenheimer Feld 280
69120 Heidelberg
Phone: +49 6221 42 4531
Fax: +49 6221 42 4557
Email: k.mueller-decker@dkfz-heidelberg.de
Dr. Claudia Galuschka

Leiterin AG Datenbanken

Deutsches Krebsforschungszentrum

Im Neuenheimer Feld 280
69120 Heidelberg
Phone: +49 6221 42-2308
Fax: +49 6221 42-2343
Email: c.galuschka@dkfz.de

The Clinical Communication Platform (CCP)

Tumor biobanks of tumor samples and patient data are important resources for the development of new diagnostic and treatment methods. Scientists in the DKTK consortium can access important data for their research from all the consortium’s sites. At the same time, the databases meet high quality and data protection requirements. The Clinical Communication Platform (CCP) was set up to secure these two aspects.

More about CCP.